Alpha Centric Advisors LLC Cyteir Therapeutics, Inc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Mar 09, 2022
SELL
$14.57 - $21.86 $14,570 - $21,860
-1,000 Closed
0 $0
Q2 2021

Mar 09, 2022
BUY
$16.8 - $21.4 $16,800 - $21,400
1,000 New
1,000 $21,000

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email